Development of novel biomedicine based on genome science

被引:21
作者
Baba, Y
机构
[1] Univ Tokushima, Fac Pharmaceut Sci, Dept Med Chem, Tokushima 7708505, Japan
[2] Japan Sci & Technol Corp, JST, CREST, Tokushima, Japan
关键词
novel biomedicine; genome science; bioindustry; pharmaceutics;
D O I
10.1016/S0928-0987(00)00201-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Towards the post genomic sequencing era, conventional drug discovery is drastically improving genomic technologies and computational advances. The completion of the entire genome sequence of many experimental organisms as well as the human organism allow us to compare several genomic sequences, comparative genomics, to get valuable information for gene discovery and functional genomics. Pharmacogenomic studies and chemical genomic investigations are quickly becoming fundamental techniques for genomic drug discovery. Additionally, progress in microchip and microarray technology has been stimulating genomic drug discovery studies. This paper reviews recent progress in human genome research, basic elements in the new strategy for drug discovery based on genome science, and future perspectives for the bio and pharmaceutical industries. (C) 2001 Elsevier Science BN. All rights reserved.
引用
收藏
页码:3 / 4
页数:2
相关论文
共 21 条